$SRDX
SURMODICS INC

2016 Q3 Form 10-K Financial Statement

#000156459017024465 Filed on December 01, 2017

View on sec.gov

Income Statement

Concept 2016 Q3 2016 Q2 2016 Q1
Revenue $18.15M $19.97M $16.70M
YoY Change 4.55% 25.5% 15.84%
Cost Of Revenue $2.840M $2.777M $2.930M
YoY Change 9.65% 27.74% 49.87%
Gross Profit $15.32M $17.20M $13.77M
YoY Change 3.65% 25.15% 10.51%
Gross Profit Margin 84.39% 86.1% 82.46%
Selling, General & Admin $5.020M $4.483M $4.850M
YoY Change 36.41% 15.78% 17.58%
% of Gross Profit 32.77% 26.07% 35.22%
Research & Development $5.300M $4.693M $4.870M
YoY Change 22.4% 21.58% 10.61%
% of Gross Profit 34.6% 27.29% 35.37%
Depreciation & Amortization $1.170M $1.406M $1.387M
YoY Change 60.27% 102.59% 96.46%
% of Gross Profit 7.64% 8.18% 10.07%
Operating Expenses $11.24M $9.176M $10.89M
YoY Change 40.32% 18.68% 27.7%
Operating Profit $4.083M $6.597M $2.240M
YoY Change -4.29% 12.63% -43.03%
Interest Expense $10.00K $260.0K -$60.00K
YoY Change -100.67% 550.0% -200.0%
% of Operating Profit 0.24% 3.94% -2.68%
Other Income/Expense, Net $10.00K $263.0K
YoY Change -6675.0%
Pretax Income $4.100M $6.860M $2.180M
YoY Change 48.01% 17.2% -51.89%
Income Tax $1.460M $2.926M $1.360M
% Of Pretax Income 35.61% 42.65% 62.39%
Net Earnings $2.577M $3.934M $821.0K
YoY Change 89.76% 0.25% -73.09%
Net Earnings / Revenue 14.2% 19.7% 4.92%
Basic Earnings Per Share $0.20 $0.31 $0.06
Diluted Earnings Per Share $0.20 $0.30 $0.06
COMMON SHARES
Basic Shares Outstanding 13.05M 13.00M
Diluted Shares Outstanding 13.28M

Balance Sheet

Concept 2016 Q3 2016 Q2 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $46.90M $44.20M $39.00M
YoY Change -15.65% -18.3% -20.57%
Cash & Equivalents $24.99M $34.66M $38.99M
Short-Term Investments $22.00M $9.500M
Other Short-Term Assets $500.0K $700.0K $2.400M
YoY Change -70.59% -36.36% 84.62%
Inventory $3.579M $3.345M $3.300M
Prepaid Expenses
Receivables $6.869M $5.859M $6.900M
Other Receivables $700.0K $0.00 $0.00
Total Short-Term Assets $58.56M $54.07M $51.70M
YoY Change -13.62% -17.21% -13.49%
LONG-TERM ASSETS
Property, Plant & Equipment $19.60M $17.18M $13.90M
YoY Change 51.15% 41.98% 11.93%
Goodwill $26.56M $26.54M
YoY Change 231.52% 231.39%
Intangibles $22.53M $22.89M
YoY Change 716.12% 858.1%
Long-Term Investments
YoY Change
Other Assets $628.0K $674.0K $5.900M
YoY Change 31.11% -65.94% 198.13%
Total Long-Term Assets $74.34M $72.85M $70.80M
YoY Change 140.41% 137.46% 128.92%
TOTAL ASSETS
Total Short-Term Assets $58.56M $54.07M $51.70M
Total Long-Term Assets $74.34M $72.85M $70.80M
Total Assets $132.9M $126.9M $122.5M
YoY Change 34.63% 32.22% 35.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.622M $1.547M $3.600M
YoY Change 107.68% 61.48% 215.51%
Accrued Expenses $6.500M $4.500M $3.200M
YoY Change 66.67% 40.63% 33.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.14M $8.069M $8.309M
YoY Change 115.64% 89.68% 133.79%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.334M $1.897M $15.30M
YoY Change 21.56% 6.69% 778.81%
Total Long-Term Liabilities $2.334M $1.897M $15.30M
YoY Change 21.56% 6.69% 778.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.14M $8.069M $8.309M
Total Long-Term Liabilities $2.334M $1.897M $15.30M
Total Liabilities $26.06M $24.11M $23.70M
YoY Change 281.18% 285.17% 329.97%
SHAREHOLDERS EQUITY
Retained Earnings $98.15M $95.50M
YoY Change 11.33% 10.02%
Common Stock $7.414M $6.416M
YoY Change 100.0% 119.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $106.8M $102.8M $98.80M
YoY Change
Total Liabilities & Shareholders Equity $132.9M $126.9M $122.5M
YoY Change 34.63% 32.22% 35.07%

Cashflow Statement

Concept 2016 Q3 2016 Q2 2016 Q1
OPERATING ACTIVITIES
Net Income $2.577M $3.934M $821.0K
YoY Change 89.76% 0.25% -73.09%
Depreciation, Depletion And Amortization $1.170M $1.406M $1.387M
YoY Change 60.27% 102.59% 96.46%
Cash From Operating Activities $6.600M $8.990M $3.300M
YoY Change 120.74% 71.56% 153.85%
INVESTING ACTIVITIES
Capital Expenditures -$3.320M -$3.890M -$600.0K
YoY Change 124.32% 1520.83% 400.0%
Acquisitions
YoY Change
Other Investing Activities -$13.06M -$9.450M -$6.600M
YoY Change 4737.04% -149.61% -418.84%
Cash From Investing Activities -$16.38M -$13.33M -$7.210M
YoY Change 836.0% -170.83% -471.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 190.0K 60.00K 200.0K
YoY Change -20.83% 100.0% 0.0%
NET CHANGE
Cash From Operating Activities 6.600M 8.990M 3.300M
Cash From Investing Activities -16.38M -13.33M -7.210M
Cash From Financing Activities 190.0K 60.00K 200.0K
Net Change In Cash -9.590M -4.280M -3.710M
YoY Change -747.97% -117.77% -207.85%
FREE CASH FLOW
Cash From Operating Activities $6.600M $8.990M $3.300M
Capital Expenditures -$3.320M -$3.890M -$600.0K
Free Cash Flow $9.920M $12.88M $3.900M
YoY Change 121.92% 135.04% 174.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
599000
CY2016Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
697000
CY2017Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
31802000
CY2017Q3 us-gaap Inventory Net
InventoryNet
3516000
CY2016Q3 us-gaap Inventory Net
InventoryNet
3579000
CY2017Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13098716
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16534000
CY2017Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2119000
CY2017Q3 us-gaap Liabilities
Liabilities
25036000
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
655000
CY2017Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5413000
CY2017Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3417000
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
102072000
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
111557000
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
136593000
CY2017Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
230000
CY2017Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.05
CY2017Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
450000
CY2017Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13094988
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13094988
CY2017Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1750000
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
9803000
CY2017Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
13114000
CY2016Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2334000
CY2016Q3 us-gaap Liabilities
Liabilities
26061000
CY2016Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
660000
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1273000
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
98146000
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
106833000
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
132894000
CY2016Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
19000
CY2016Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.05
CY2016Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
6754000
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22942000
CY2017Q3 us-gaap Assets Current
AssetsCurrent
60883000
CY2017Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7211000
CY2016Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1622000
CY2015 us-gaap Royalty Revenue
RoyaltyRevenue
31763000
CY2017 us-gaap Cost Of Goods Sold
CostOfGoodsSold
11422000
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19601000
CY2016Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
925000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
3926000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18241000
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-848000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16948000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3107000
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6963000
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.90
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12998000
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13029000
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13389000
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13219000
CY2016 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-68000
CY2017 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
348000
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
96000
CY2016Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13208443
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13208443
CY2016Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
450000
CY2016Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
10135000
CY2016Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
13592000
CY2017 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
32790000
CY2016Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1508000
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
8000
CY2017 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
35000
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
216000
CY2017 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
216000
CY2017Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1481000
CY2016Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1200000
CY2017Q3 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
0
CY2016Q3 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
0
CY2017 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
700000
CY2016 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
300000
CY2015 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
300000
CY2017Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1835000
CY2017Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3822000
CY2017Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2396000
CY2016Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2170000
CY2017 us-gaap Revenues
Revenues
73112000
CY2016Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5418000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31817000
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18498000
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20478000
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
431000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
11947000
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.77
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.76
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13153000
CY2017Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
4027000
CY2016Q3 us-gaap Assets Current
AssetsCurrent
58558000
CY2017Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20562000
CY2016Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
22525000
CY2017Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
897000
CY2016Q3 us-gaap Goodwill
Goodwill
26555000
CY2017Q3 us-gaap Assets
Assets
136593000
CY2016Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
628000
CY2016Q3 us-gaap Assets
Assets
132894000
CY2016Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
21954000
CY2016Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
472000
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24987000
CY2016Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6869000
CY2017Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1221000
CY2016Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
5027000
CY2017 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
560000
CY2017 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2016 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16165000
CY2015 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14906000
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-70000
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
89000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7033000
CY2015 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
100000
CY2016 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
100000
CY2017Q1 dei Entity Public Float
EntityPublicFloat
176000000
CY2017Q3 us-gaap Goodwill
Goodwill
27282000
CY2016 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
30999000
CY2017 us-gaap Royalty Revenue
RoyaltyRevenue
31787000
CY2016 us-gaap Royalty Revenue
RoyaltyRevenue
33203000
CY2016 us-gaap Cost Of Goods Sold
CostOfGoodsSold
10908000
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18000000
CY2016 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
3187000
CY2017 srdx Acquisition Related Intangible Asset Amortization
AcquisitionRelatedIntangibleAssetAmortization
2419000
CY2016 srdx Acquisition Related Intangible Asset Amortization
AcquisitionRelatedIntangibleAssetAmortization
2422000
CY2015 srdx Acquisition Related Intangible Asset Amortization
AcquisitionRelatedIntangibleAssetAmortization
619000
CY2017 srdx Accretion Income Expense Including Asset Retirement Obligations
AccretionIncomeExpenseIncludingAssetRetirementObligations
127000
CY2016 srdx Accretion Income Expense Including Asset Retirement Obligations
AccretionIncomeExpenseIncludingAssetRetirementObligations
-1492000
CY2015 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
2500000
CY2017 us-gaap Costs And Expenses
CostsAndExpenses
66009000
CY2016 us-gaap Costs And Expenses
CostsAndExpenses
54507000
CY2015 us-gaap Costs And Expenses
CostsAndExpenses
42809000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
7103000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
16859000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
19089000
CY2017 us-gaap Investment Income Net
InvestmentIncomeNet
390000
CY2016 us-gaap Investment Income Net
InvestmentIncomeNet
63000
CY2015 us-gaap Investment Income Net
InvestmentIncomeNet
156000
CY2017 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-504000
CY2016 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-481000
CY2015 us-gaap Impairment Of Investments
ImpairmentOfInvestments
1500000
CY2017 srdx Gain Loss On Sale Of Strategic Investment And Other Nonoperating Income Expense
GainLossOnSaleOfStrategicInvestmentAndOtherNonoperatingIncomeExpense
44000
CY2016 srdx Gain Loss On Sale Of Strategic Investment And Other Nonoperating Income Expense
GainLossOnSaleOfStrategicInvestmentAndOtherNonoperatingIncomeExpense
507000
CY2015 srdx Gain Loss On Sale Of Strategic Investment And Other Nonoperating Income Expense
GainLossOnSaleOfStrategicInvestmentAndOtherNonoperatingIncomeExpense
496000
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6294000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
9985000
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.92
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13289000
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
49000
CY2015 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1208000
CY2015 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
315000
CY2017 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2095000
CY2016 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1336000
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2144000
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1268000
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1523000
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6070000
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11253000
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10424000
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
98751000
CY2015 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
279000
CY2015 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
20000000
CY2015 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
825000
CY2015 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
432000
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2381000
CY2016 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
270000
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1546000
CY2015 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
22199000
CY2016 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
25859000
CY2015 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
270000
CY2017 us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
43000
CY2016 us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
513000
CY2015 us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
21000
CY2015 srdx Cash Received Paid From Transferred To Discontinued Operations
CashReceivedPaidFromTransferredToDiscontinuedOperations
-45000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-16189000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-55468000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
16694000
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
444000
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
494000
CY2016 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1953000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3844000
CY2017 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
4702000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3472000
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5555000
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4873000
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2805000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
3472000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
3844000
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
2381000
CY2017 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-127000
CY2016 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1492000
CY2017 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-474000
CY2016 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-444000
CY2017 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
427000
CY2017 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
43000
CY2016 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
514000
CY2015 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
492000
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1000000
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
261000
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
93000
CY2015 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
432000
CY2017 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-6000
CY2016 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
66000
CY2015 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
39000
CY2017 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
208000
CY2016 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-13000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
528000
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-911000
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2727000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-97000
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
143000
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
162000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
599000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-409000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-141000
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
368000
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3710000
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
373000
CY2017 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-59000
CY2016 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
76000
CY2015 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-309000
CY2017 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-124000
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-129000
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-13000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
14053000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
25166000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
15066000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6432000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8192000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1877000
CY2016 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
89000
CY2015 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
42000
CY2017 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
73671000
CY2016 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
24517000
CY2015 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
3376000
CY2017 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
63871000
CY2016 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
2498000
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
710000
CY2017 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4702000
CY2015 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
20000000
CY2017 srdx Purchase Of Common Stock To Pay Employee Taxes
PurchaseOfCommonStockToPayEmployeeTaxes
2156000
CY2016 srdx Purchase Of Common Stock To Pay Employee Taxes
PurchaseOfCommonStockToPayEmployeeTaxes
388000
CY2015 srdx Purchase Of Common Stock To Pay Employee Taxes
PurchaseOfCommonStockToPayEmployeeTaxes
825000
CY2017 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
96000
CY2015 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
432000
CY2016 srdx Payment Of Contingent Consideration
PaymentOfContingentConsideration
305000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-6510000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-199000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-19683000
CY2017 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
193000
CY2016 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-100000
CY2017 srdx Net Cash Provided By Used In Continuing Operations Including Exchange Rate Effect
NetCashProvidedByUsedInContinuingOperationsIncludingExchangeRateEffect
-8453000
CY2016 srdx Net Cash Provided By Used In Continuing Operations Including Exchange Rate Effect
NetCashProvidedByUsedInContinuingOperationsIncludingExchangeRateEffect
-30601000
CY2015 srdx Net Cash Provided By Used In Continuing Operations Including Exchange Rate Effect
NetCashProvidedByUsedInContinuingOperationsIncludingExchangeRateEffect
12077000
CY2015 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-45000
CY2015 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
45000
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-8453000
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-30601000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
12077000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
55588000
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43511000
CY2017 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2114000
CY2016 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6710000
CY2015 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6510000
CY2017 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
109000
CY2016 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
50000
CY2015 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
22000
CY2016 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
12584000
CY2017 srdx Noncash Transactions Issuance Of Performance Shares Restricted And Deferred Stock Units
NoncashTransactionsIssuanceOfPerformanceSharesRestrictedAndDeferredStockUnits
2022000
CY2016 srdx Noncash Transactions Issuance Of Performance Shares Restricted And Deferred Stock Units
NoncashTransactionsIssuanceOfPerformanceSharesRestrictedAndDeferredStockUnits
1472000
CY2015 srdx Noncash Transactions Issuance Of Performance Shares Restricted And Deferred Stock Units
NoncashTransactionsIssuanceOfPerformanceSharesRestrictedAndDeferredStockUnits
2250000
CY2016 srdx Noncash Transaction Accrual Of Employee Taxes On Common Stock Exercises
NoncashTransactionAccrualOfEmployeeTaxesOnCommonStockExercises
1585000
CY2015 srdx Noncash Transaction Accrual Of Business Combination Contingent Consideration
NoncashTransactionAccrualOfBusinessCombinationContingentConsideration
305000
CY2017 us-gaap Revenue Recognition Sales Of Goods
RevenueRecognitionSalesOfGoods
<div> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;font-style:italic;font-family:Calibri;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Product sales.<font style="font-style:normal;">&#160;Product sales to third parties consist of original equipment manufacturer (OEM) and distributor sales and are recognized at the time of shipment. The Company&#8217;s sa</font><font style="font-style:normal;">les terms provide no right of return outside of the standard warranty policy. Payment terms are generally set at 30-45&#160;days.</font></p></div>
CY2017 us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<div> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.27%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Calibri;font-size:10pt;text-transform:none;font-variant: normal;">Deferred Revenue</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Amounts received prior to satisfying the above revenue recognition criteria are recorded as deferred revenue in the accompanying consolidated balance sheets, with deferred revenue to be recognized beyond one year being classified as non-current deferred revenue. The Company had current and non-current deferred revenue of $0.3 million and $0.4 million as of September 30, 2017 and 2016, respectively included in other accrued liabilities (current) and other long-term liabilities (long-term).</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer overpayments are accounted for as a liability until all criteria for revenue recognition have been met. As of September 30, 2017, and 2016 the Company has recorded a liability of less than $0.1 million and $0.9 million, respectively, for customer royalty overpayments, which are included in other accrued liabilities.</p></div>
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.27%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Calibri;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Ultimate results could differ from those estimates.</p></div>
CY2017 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities
0
CY2016 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities
0
CY2015 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities
0
CY2017Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
31817000
CY2017Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
15000
CY2017Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
31802000
CY2016Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
22019000
CY2016Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
65000
CY2016Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
21954000
CY2017Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
0
CY2016Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
0
CY2017 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0
CY2016 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0
CY2015 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
500000
CY2015 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
100000
CY2017Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
1603000
CY2016Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
1766000
CY2017Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
659000
CY2016Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
492000
CY2017Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1254000
CY2016Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1321000
CY2017 us-gaap Depreciation
Depreciation
3000000
CY2016 us-gaap Depreciation
Depreciation
2300000
CY2015 us-gaap Depreciation
Depreciation
2000000
CY2017Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
29927000
CY2016Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
26979000
CY2017 us-gaap Transfer To Investments
TransferToInvestments
2000
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
800000
CY2017Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
31400000
CY2017Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10838000
CY2016Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
31129000
CY2016Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8604000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2661000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2661000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2486000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2347000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2307000
CY2017 srdx Impairment Losses Of Intangible Assets Indefinite Lived Excluding Goodwill Other
ImpairmentLossesOfIntangibleAssetsIndefiniteLivedExcludingGoodwillOther
0
CY2017 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2017Q3 srdx Goodwill Subject To Revaluation Due To Fluctuations In Exchange Rates
GoodwillSubjectToRevaluationDueToFluctuationsInExchangeRates
13400000
CY2015Q3 us-gaap Goodwill
Goodwill
8010000
CY2016 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
17892000
CY2016 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
653000
CY2017 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
727000
CY2017 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2016 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2015 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2017Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
501000
CY2016Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
262000
CY2017Q3 srdx Accrued Clinical Study Expense Current
AccruedClinicalStudyExpenseCurrent
411000
CY2016Q3 srdx Accrued Clinical Study Expense Current
AccruedClinicalStudyExpenseCurrent
283000
CY2017Q3 srdx Accrued Inventory Purchases Current
AccruedInventoryPurchasesCurrent
596000
CY2016Q3 srdx Accrued Inventory Purchases Current
AccruedInventoryPurchasesCurrent
315000
CY2017Q3 srdx Due To Customers Current
DueToCustomersCurrent
41000
CY2016Q3 srdx Due To Customers Current
DueToCustomersCurrent
881000
CY2017Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
62000
CY2016Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
180000
CY2017Q3 srdx Other Accrued Liabilities Other Current
OtherAccruedLiabilitiesOtherCurrent
224000
CY2016Q3 srdx Other Accrued Liabilities Other Current
OtherAccruedLiabilitiesOtherCurrent
249000
CY2017 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
100000
CY2017 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
3926000
CY2016 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
9985000
CY2015 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
11947000
CY2017 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
236000
CY2016 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
221000
CY2015 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
260000
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
700000
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500000
CY2017Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
14900000
CY2016Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
14500000
CY2017Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
0
CY2016Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
0
CY2017 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2016 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2017 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0
CY2017 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
196190
CY2017 srdx Stock Repurchased During Period Average Price
StockRepurchasedDuringPeriodAveragePrice
23.97
CY2017Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
25300000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3472000
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3844000
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2381000
CY2017Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
4700000
CY2017 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M7D
CY2017Q3 srdx Performance Share Awards Fully Expensed
PerformanceShareAwardsFullyExpensed
1500000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.63
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.95
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.26
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0174
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0189
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0143
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y7M7D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y7M7D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y6M
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.34
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.37
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.43
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
10000000
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
6100000
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y9M19D
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
35.35
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
20.10
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
20.63
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
15.68
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
6385000
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-13000
CY2016 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
142000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
100000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
5100000
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1210619
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
164401
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
166422
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
90590
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1118008
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
241582
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
437850
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
94415
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
827325
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
229039
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
6819
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
47640
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1001905
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
547051
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
20.35
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
21.24
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
14.54
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
31.52
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
21.30
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
24.08
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
13.89
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
30.65
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
21.54
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
20.80
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
6065000
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
106000
CY2015 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
30000
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
6201000
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
58000
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
35000
CY2016 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
135000
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
2461000
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
5932000
CY2016 srdx Income Tax Reconciliation Acquisition Related Transaction Costs
IncomeTaxReconciliationAcquisitionRelatedTransactionCosts
768000
CY2017 srdx Income Tax Reconciliation Contingent Consideration Gain Expense
IncomeTaxReconciliationContingentConsiderationGainExpense
45000
CY2016 srdx Income Tax Reconciliation Contingent Consideration Gain Expense
IncomeTaxReconciliationContingentConsiderationGainExpense
-522000
CY2017 srdx Income Tax Reconciliation Unrealized Foreign Currency Exchange Loss On Contingent Consideration Obligation
IncomeTaxReconciliationUnrealizedForeignCurrencyExchangeLossOnContingentConsiderationObligation
170000
CY2017 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-338000
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
47000
CY2017Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1200000
CY2015Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
900000
CY2017Q3 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
500000
CY2016Q3 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
600000
CY2015Q3 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
600000
CY2017 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
0
CY2015 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
67000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
330000
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-607000
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
16000
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
665000
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-2500000
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
348000
CY2017 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
-52000
CY2016 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
258000
CY2015 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
34000
CY2017 us-gaap Income Tax Reconciliation Deductions Qualified Production Activities
IncomeTaxReconciliationDeductionsQualifiedProductionActivities
313000
CY2016 us-gaap Income Tax Reconciliation Deductions Qualified Production Activities
IncomeTaxReconciliationDeductionsQualifiedProductionActivities
280000
CY2015 us-gaap Income Tax Reconciliation Deductions Qualified Production Activities
IncomeTaxReconciliationDeductionsQualifiedProductionActivities
268000
CY2017 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
706000
CY2016 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
571000
CY2015 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
74000
CY2016 srdx Income Tax Reconciliation Gain On Strategic Investment And Corporate Subsidiary
IncomeTaxReconciliationGainOnStrategicInvestmentAndCorporateSubsidiary
2630000
CY2017 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
948000
CY2016 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
622000
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-214000
CY2017 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
-200000
CY2016 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
600000
CY2017Q3 srdx Deferred Tax Assets Liabilities Property Plant And Equipment
DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment
-3335000
CY2016Q3 srdx Deferred Tax Assets Liabilities Property Plant And Equipment
DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment
-2257000
CY2017Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1123000
CY2016Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1153000
CY2017Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3370000
CY2016Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3113000
CY2017Q3 srdx Deferred Tax Assets Impaired Investment
DeferredTaxAssetsImpairedInvestment
2701000
CY2016Q3 srdx Deferred Tax Assets Impaired Investment
DeferredTaxAssetsImpairedInvestment
2701000
CY2017Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3627000
CY2016Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3324000
CY2017Q3 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
242000
CY2016Q3 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
110000
CY2017Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
810000
CY2016Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
730000
CY2017Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4511000
CY2016Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3847000
CY2017Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4027000
CY2016Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
5027000
CY2017 srdx Operating Loss Carryforwards Remaining Period
OperatingLossCarryforwardsRemainingPeriod
P10Y
CY2015Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1248000
CY2014Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1216000
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
77000
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
50000
CY2016 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
21000
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
10000
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
365000
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
146000
CY2016 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
161000
CY2015 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
154000
CY2017 us-gaap License Costs
LicenseCosts
200000
CY2017Q3 srdx Exchange Rates
ExchangeRates
1.1801
CY2017Q3 srdx Annual License Maintenance Fee Payable Year One
AnnualLicenseMaintenanceFeePayableYearOne
2400000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
100000
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
100000
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
100000
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
114000
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
73000
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
74000
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
12000
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
273000
CY2017 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2017 srdx Number Of Sources Of Revenues
NumberOfSourcesOfRevenues
2
CY2016Q4 us-gaap Revenues
Revenues
17761000
CY2017Q1 us-gaap Revenues
Revenues
17503000
CY2016 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
0
CY2015Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
2500000
CY2015Q3 us-gaap Loss Contingency Receivable
LossContingencyReceivable
500000
CY2015Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
500000
CY2015Q3 srdx Pre Tax Compensation Expense
PreTaxCompensationExpense
2500000
CY2017 srdx Additional Shares Of Common Stock To Stockholders
AdditionalSharesOfCommonStockToStockholders
480059
CY2017 srdx License Agreement Commencement Date
LicenseAgreementCommencementDate
2006-03
CY2017 us-gaap License Costs
LicenseCosts
236000
CY2017Q2 us-gaap Revenues
Revenues
17790000
CY2017Q3 us-gaap Revenues
Revenues
20058000
CY2016Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
3268000
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
2300000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
506000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
720000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
400000
CY2016Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2016Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2015Q4 us-gaap Revenues
Revenues
16541000
CY2016Q1 us-gaap Revenues
Revenues
16699000
CY2016Q2 us-gaap Revenues
Revenues
19972000
CY2016Q3 us-gaap Revenues
Revenues
18154000
CY2015Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
3939000
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2240000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
6597000
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4083000
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
2653000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
821000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
3934000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
2577000
CY2015Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2015Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2016Q2 us-gaap Royalty Expense
RoyaltyExpense
2900000

Files In Submission

Name View Source Status
0001564590-17-024465-index-headers.html Edgar Link pending
0001564590-17-024465-index.html Edgar Link pending
0001564590-17-024465.txt Edgar Link pending
0001564590-17-024465-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g2017120122175290213782.jpg Edgar Link pending
g2017120122175290813782.jpg Edgar Link pending
g2017120122175291013783.jpg Edgar Link pending
g2017120122182888211346.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
srdx-10k_20170930.htm Edgar Link pending
srdx-20170930.xml Edgar Link completed
srdx-20170930.xsd Edgar Link pending
srdx-20170930_cal.xml Edgar Link unprocessable
srdx-20170930_def.xml Edgar Link unprocessable
srdx-20170930_lab.xml Edgar Link unprocessable
srdx-20170930_pre.xml Edgar Link unprocessable
srdx-ex1017_242.htm Edgar Link pending
srdx-ex21_12.htm Edgar Link pending
srdx-ex23_8.htm Edgar Link pending
srdx-ex311_7.htm Edgar Link pending
srdx-ex312_10.htm Edgar Link pending
srdx-ex321_13.htm Edgar Link pending
srdx-ex322_6.htm Edgar Link pending